Leekam SR, Prior MR, Uljarevic M. Restricted and repetitive behaviors in autism spectrum disorders: a review of research in the last decade. Psychol Bull. 2011;137:562–93.
Oakes A, Thurman AJ, McDuffie A, Bullard LM, Hagerman RJ, Abbeduto L. Characterising repetitive behaviours in young boys with fragile X syndrome. J Intellect Disabil Res. 2016;60:54–67.
Article CAS PubMed Google Scholar
Bagni C, Zukin RS. A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron. 2019;101:1070–88.
Article CAS PubMed PubMed Central Google Scholar
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, et al. Nat Rev Neurosci. 2010;11:760–72.
Article CAS PubMed PubMed Central Google Scholar
Howard CD, Li H, Geddes CE, Jin X. Dynamic nigrostriatal dopamine biases action selection. Neuron. 2017;93:1436–1450e1438.
Article CAS PubMed PubMed Central Google Scholar
Ernst AM, Smelik PG. Site of action of dopamine and apomorphine on compulsive gnawing behavior in rats. Experientia. 1966;22:837–8.
Article CAS PubMed Google Scholar
Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci. 2000;3:377–83.
Article CAS PubMed Google Scholar
Berridge KC, Aldridge JW. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists. Synapse. 2000;37:205–15.
Article CAS PubMed Google Scholar
Presti MF, Mikes HM, Lewis MH. Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation. Pharmacol Biochem Behav. 2003;74:833–9.
Article CAS PubMed Google Scholar
Berridge KC, Aldridge JW, Houchard KR, Zhuang X. Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette’s. BMC Biol. 2005;3:4.
Article PubMed PubMed Central Google Scholar
Cromwell HC, Berridge KC, Drago J, Levine MS. Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci. 1998;10:2426–32.
Article CAS PubMed Google Scholar
Lee Y, Kim H, Kim J, Park J, Choi J, Lee J, et al. Excessive D1 dopamine receptor activation in the dorsal striatum promotes autistic-like behaviors. Mol Neurobiol. 2018;55:5658–71.
Article CAS PubMed Google Scholar
Xue J, Qian D, Zhang B, Yang J, Li W, Bao Y, et al. Midbrain dopamine neurons arbiter OCD-like behavior. Proc Natl Acad Sci USA. 2022;119:e2207545119.
Article CAS PubMed PubMed Central Google Scholar
Pavăl DA. Dopamine hypothesis of autism spectrum disorder. Dev Neurosci. 2017;39:355–60.
Pavăl D, Micluția IV. The dopamine hypothesis of autism spectrum disorder revisited: current status and future prospects. Dev Neurosci. 2021;43:73–83.
Gandhi T, Lee CC. Neural mechanisms underlying repetitive behaviors in rodent models of autism spectrum disorders. Front Cell Neurosci. 2021;14:592710.
Article PubMed PubMed Central Google Scholar
Kosillo P, Bateup HS. Dopaminergic dysregulation in syndromic autism spectrum disorders: insights from genetic mouse models. Front Neural Circuits. 2021;15:700968.
Article CAS PubMed PubMed Central Google Scholar
Longo F, Aryal S, Anastasiades PG, Maltese M, Baimel C, Albanese F, et al. Cell-type-specific disruption of cortico-striatal circuitry drives repetitive patterns of behavior in fragile X syndrome model mice. Cell Rep. 2023;42:112901.
Article CAS PubMed PubMed Central Google Scholar
Mercaldo V, Vidimova B, Gastaldo D, Fernández E, Lo AC, Cencelli G, et al. Altered striatal actin dynamics drives behavioral inflexibility in a mouse model of fragile X syndrome. Neuron. 2023;111:1760–75.
Article CAS PubMed Google Scholar
Chao OY, Pathak SS, Zhang H, Dunaway N, Li JS, Mattern C, et al. Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism. Mol Brain. 2020;13:111.
Article CAS PubMed PubMed Central Google Scholar
Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ. Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. PLoS One. 2013;8:e77896.
Article CAS PubMed PubMed Central Google Scholar
Gruss M, Braun K. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Neural Plast. 2001;8:285–98.
Article CAS PubMed PubMed Central Google Scholar
Sørensen EM, Bertelsen F, Weikop P, Skovborg MM, Banke T, Drasbek KR, et al. Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse. Behav Pharmacol. 2015;26:733–40.
Ventura R, Pascucci T, Catania MV, Musumeci SA, Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol. 2004;15:433–42.
Article CAS PubMed Google Scholar
Fulks JL, O’bryhim BE, Wenzel SK, Fowler SC, Vorontsova E, Pinkston JW, et al. Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile X mental retardation syndrome. ACS Chem. Neurosci. 2010;1:679–90.
Article CAS PubMed PubMed Central Google Scholar
Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 5th Edition - Hardback ISBN: 9780128161579 (2019).
Ledonne A, Nobili A, Latagliata EC, Cavallucci V, Guatteo E, Puglisi-Allegra S, et al. Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry. 2015;20:959–73.
Article CAS PubMed Google Scholar
Ledonne A, Mango D, Latagliata EC, Chiacchierini G, Nobili A, Nisticò R, et al. Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory. Pharmacol Res. 2018;130:12–24.
Article CAS PubMed Google Scholar
Gu Y, Tran T, Murase S, Borrell A, Kirkwood A, Quinlan EM. Neuregulin-dependent regulation of fast-spiking interneuron excitability controls the timing of the critical period. J Neurosci. 2016;36:10285–95.
Article CAS PubMed PubMed Central Google Scholar
Price R, Ferrari E, Gardoni F, Mercuri NB, Ledonne A. Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons. Pharmacol Res. 2020;160:105185.
Article CAS PubMed Google Scholar
Ledonne A, Massaro Cenere M, Paldino E, D’Angelo V, D’Addario SL, Casadei N, et al. Morpho-functional changes of nigral dopamine neurons in an α-synuclein model of Parkinson’s disease. Mov Disord. 2023;38:256–66.
Comments (0)